RE:Market Est.You realize that $2.17 was due to the sale of most of the company assets right. Ryplazim, plasma research, plasma collection centers, PRV; all sold.
One time event and they now have no revenue to speak of.
You are the master of your own destiny, no one else my friend.
inventors wrote: The market analysts report lmnl made $2.17/share vs -0.27/share.
I'm holding for next year...bounce to 14 mda, 21 mda, 50 would be nice....200?